Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate
2007-04-03
2007-04-03
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
C424S204100, C435S320100
Reexamination Certificate
active
10406818
ABSTRACT:
An alphavirus vector system comprising nucleic acid of a human papilloma virus origin is disclosed. A method of treating or preventing cervical cancer is also disclosed. The method includes administering the alphavirus vector system and/or a cell comprising nucleic acid derived from human papilloma virus (HPV) to a subject. The alphavirus vector system or the cell may be administered as a vaccine.
REFERENCES:
patent: 5789245 (1998-08-01), Dubensky, Jr. et al.
patent: 5814482 (1998-09-01), Dubensky, Jr. et al.
patent: 5843723 (1998-12-01), Dubensky, Jr. et al.
patent: 6015686 (2000-01-01), Dubensky, Jr. et al.
patent: 6015694 (2000-01-01), Dubensky, Jr. et al.
patent: 6342372 (2002-01-01), Dubensky, Jr. et al.
patent: 6376236 (2002-04-01), Dubensky, Jr. et al.
patent: 0 711 829 (1996-05-01), None
patent: WO 99/28487 (1999-06-01), None
patent: WO 02/29074 (2002-04-01), None
Strauss et al. Microbiological Reviews, 1994, vol. 58, No. 3, pp. 491-562.
International Prelmiinary Examination Report, International Application No. PCT/NL01/00740, dated Oct. 18, 2002.
International Search Report, International Application No. PCT/NL01/00740, dated Jul. 12, 2002 (3 pages).
Berglund, Peter, et al., “Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice,” 17(5) VACCINE 497-507 (Feb. 5, 1999).
Borysiewicz, L.K., et al., “A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer,” 347(9014) LANCET 1523-27 (Jun. 1, 1996).
Boursnell, M.E.G., et al., “Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer,” 14(16) VACCINE 1485-94 (Nov. 1, 1996).
Daemen, T., et al., “Genetic immunization against cervical carcinoma: induction of cytotoxic T Lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7,” 7(21) Gene Therapy 1859-66 (Nov. 2000).
Heino, Pirkko, et al., “Human Papillomavirus Type 16 Capsid Proteins Produced from Recombinant Semliki Forest Virus Assemble into Virus-like Particles,” 214(2) VIROLOGY 349-59 (Dec. 20, 1995).
Withoff, S., et al., “Development of cytokine-transduced, autologous whole-cell cancer vaccines, using recombinant Semliki Forest virus,” 39 Proceedings of the American Association for Cancer Research Annual 533 (Mar. 1998).
Daemen Catharina Arnoldine H. H.
Holtrop Marijke
Regts Djoeke Geesje
Wilschut Jan Christiaan
Rijksuniversiteit Groningen
Salimi Ali R.
TraskBritt
LandOfFree
Genetic immunization against cervical carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic immunization against cervical carcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic immunization against cervical carcinoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3744357